NFC:LSE-Next Fifteen Communications Group plc (GBX)

COMMON STOCK | Advertising Agencies | LSE

Last Closing Price

GBX 872.00

Change

0.00 (0.00)%

Market Cap

GBX 0.81B

Volume

0.06M

Average Target Price

GBX 900.00 (+3.21%)
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict

About

Next Fifteen Communications Group plc, together with its subsidiaries, provides communications services in the United Kingdom, Europe, Africa, the United States, and the Asia Pacific. It offers strategy and insight, online marketing, corporate and internal communications, media training, brand and message consultancy, market research, digital, marketing communications, and creative and content, as well as public, media, analyst, and investor relations services; and digital and technology products and services. The company provides its services under the Agent3, encore, Publitek, Beyond, Savanta, MBooth, MBooth Health, MACH 49, MIGHTY SOCIAL, Archetype, Conversion Rate Experts, Twogether, ODD, The Blueshirt Group, OutCast, Velocity, SMG., ELVIS, Brandwidth, Activate, Planning-inc, and Palladium brands. Next Fifteen Communications Group plc was incorporated in 1981 and is based in London, the United Kingdom. Address: 75 Bermondsey Street, London, United Kingdom, SE1 3XF

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2021-06-20 )

Largest Industry Peers for Advertising Agencies

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
WPP:LSE WPP plc

N/A

GBX11.73B 11.56 5.61
SFOR:LSE S4 Capital plc

N/A

GBX3.27B N/A 80.29
ASCL:LSE Ascential plc

N/A

GBX1.63B 151.68 19.92
YOU:LSE YouGov plc

N/A

GBX1.31B 163.89 41.04
TRMR:LSE Tremor International Ltd

N/A

GBX0.90B 44.90 21.15
FOUR:LSE 4imprint Group plc

N/A

GBX0.78B 357.69 84.26
OOUT:LSE Ocean Outdoor Limited

N/A

GBX0.43B N/A 16.37
PEBB:LSE The Pebble Group Plc

N/A

GBX0.26B 65.63 28.88
SAA:LSE M&C Saatchi plc

N/A

GBX0.18B 3.83 10.28
CLL:LSE Cello Health plc

N/A

GBX0.18B 36.10 13.95

ETFs Containing NFC

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Advertising Agencies)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 65.78% 71% C- 95% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 65.78% 71% C- 95% A
Trailing 12 Months  
Capital Gain 135.68% 79% C+ 94% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 135.68% 79% C+ 94% A
Trailing 5 Years  
Capital Gain 243.98% 86% B 94% A
Dividend Return 9.71% 60% D- 35% F
Total Return 253.69% 86% B 93% A
Average Annual (5 Year Horizon)  
Capital Gain 18.64% 79% C+ 78% C+
Dividend Return 1.19% 33% F 45% F
Total Return 19.83% 74% C 77% C+
Risk Return Profile  
Volatility (Standard Deviation) 39.87% 63% D 32% F
Risk Adjusted Return 49.73% 79% C+ 68% D+
Market Capitalization 0.81B 78% C+ 74% C
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Advertising Agencies)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 194.00 13% F 5% F
Price/Book Ratio 6.91 19% F 14% F
Price / Cash Flow Ratio 12.53 52% F 35% F
EV/EBITDA 24.53 37% F 28% F
Management Effectiveness  
Return on Equity -3.44% 50% F 41% F
Return on Invested Capital 7.86% 78% C+ 72% C-
Return on Assets 2.93% 87% B+ 63% D
Debt to Equity Ratio 6.68% 67% D+ 76% C
Technical Ratios  
Short Ratio N/A N/A N/A N/A N/A
Short Percent N/A N/A N/A N/A N/A
Beta 1.30 48% F 18% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector